Insider · CIK 0001105941
PERRY DAVID P
Reports to the SEC for 4 companies · PALO ALTO, CA
Transactions
47
Companies
4
Filings
9
CIK
0001105941
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-02-09 | Better Therapeutics, Inc.A Award | +$160K |
| 2024-01-09 | Better Therapeutics, Inc.A Award | +$250K |
| 2023-12-18 | Better Therapeutics, Inc.A Award | — |
| 2023-07-27 | Better Therapeutics, Inc.P Purchase | +$900K |
| 2023-06-07 | Better Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-04-10 | Better Therapeutics, Inc.P Purchase | +$1.1M |
| 2023-04-10 | Better Therapeutics, Inc.P Purchase | +$3M |
| 2022-09-16 | Better Therapeutics, Inc.P Purchase | +$81K |
| 2022-09-15 | Better Therapeutics, Inc.P Purchase | +$21.6K |
| 2022-06-09 | Better Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-10-28 | Better Therapeutics, Inc.A Award | — |
| 2021-10-28 | Better Therapeutics, Inc.A Award | — |
| 2021-10-28 | Better Therapeutics, Inc.A Award | — |
| 2021-10-28 | Better Therapeutics, Inc.P Purchase | +$2M |
| 2021-10-28 | Better Therapeutics, Inc.A Award | +$1M |
| 2021-10-28 | Better Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-06-09 | Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-06-08 | Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-05-26 | Better Therapeutics, Inc.P Purchase | +$199K |
| 2021-05-24 | Better Therapeutics, Inc.P Purchase | +$79.5K |
| 2021-05-21 | Better Therapeutics, Inc.P Purchase | +$79.6K |
| 2021-05-14 | Better Therapeutics, Inc.P Purchase | +$30.4K |
| 2021-05-13 | Better Therapeutics, Inc.P Purchase | +$69.5K |
| 2021-05-04 | Better Therapeutics, Inc.P Purchase | +$34.5K |
| 2021-04-30 | Better Therapeutics, Inc.P Purchase | +$19.9K |
| 2020-06-17 | Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2019-06-12 | Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2014-03-05 | Anacor Pharmaceuticals, Inc.S Sale | −$152K |
| 2014-03-04 | Anacor Pharmaceuticals, Inc.S Sale | −$152K |
| 2014-03-04 | Anacor Pharmaceuticals, Inc.S Sale | −$1.01M |
| 2014-02-07 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2014-02-05 | Anacor Pharmaceuticals, Inc.S Sale | −$125K |
| 2014-02-04 | Anacor Pharmaceuticals, Inc.S Sale | −$130K |
| 2014-01-09 | Anacor Pharmaceuticals, Inc.S Sale | −$124K |
| 2014-01-08 | Anacor Pharmaceuticals, Inc.S Sale | −$122K |
| 2014-01-08 | Anacor Pharmaceuticals, Inc.S Sale | −$815K |
| 2013-12-09 | Anacor Pharmaceuticals, Inc.M Exercise/Conversion | +$171K |
| 2013-12-09 | Anacor Pharmaceuticals, Inc.S Sale | −$173K |
| 2013-12-09 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2013-12-06 | Anacor Pharmaceuticals, Inc.S Sale | −$86.2K |
| 2013-12-06 | Anacor Pharmaceuticals, Inc.S Sale | −$166K |
| 2013-12-05 | Anacor Pharmaceuticals, Inc.S Sale | −$184K |
| 2013-12-05 | Anacor Pharmaceuticals, Inc.S Sale | −$45.4K |
| 2013-04-12 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2012-03-13 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2011-03-31 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2004-04-22 | NEXPRISE INCNon-qualified Stock Option (right to buy)A Award | — |
Recent filings
- 4PERRY DAVID P0000950170-24-014898SEC(opens sec.gov)
- 4PERRY DAVID P0000950170-24-003637SEC(opens sec.gov)
- 4PERRY DAVID P0000950170-23-071963SEC(opens sec.gov)
- 4PERRY DAVID P0000950170-23-035685SEC(opens sec.gov)
- 4PERRY DAVID P0000950170-23-027333SEC(opens sec.gov)
- 4PERRY DAVID P0000899243-23-011231SEC(opens sec.gov)
- 4PERRY DAVID P0000899243-22-031420SEC(opens sec.gov)
- 4PERRY DAVID P0000899243-22-021932SEC(opens sec.gov)
- 4PERRY DAVID P0000899243-21-042250SEC(opens sec.gov)
Companies
Address
1020 EAST MEADOW CIRCLE
PALO ALTO, CA, 94303